Publications by authors named "Michael Weichenthal"

Claim this Profile
E
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg.
Noah Zimmermann, Julian Kött, Tim Zell, Ali Zeinal Abedini, Chiara L Blomen, Michael Weichenthal

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.
Dirk Tomsitz, Elisabeth Livingstone, Carmen Loquai, Martin Kaatz, Ulrike Leiter, Michael Weichenthal

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.
Selma Ugurel, Nessr Abu Rached, Thilo Gambichler, Miriam Mengoni, Thomas Tüting, Michael Weichenthal

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bexarotene signaling in human B and T lymphocytes induces gut-homing receptor expression.
Sina Kaiser, Ina Suhrkamp, Jinru He, Charlotte Helf, Christian D Sadik, Michael Weichenthal

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, Michael Weichenthal, Peter Mohr

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma.
Viola K DeTemple, Martin Kaatz, Eggert Stockfleth, Christina Scheel, Yenny Angela, Michael Weichenthal

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study.
Michael Weichenthal, Eva Ellebaek, Joanna Mangana, Nethanel Asher, Iva Gavrilova

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG.
Sören Reinhard, Jochen Sven Utikal, Anne Zaremba, Georg Lodde, Imke von Wasielewski, Michael Weichenthal

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status.
Jan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Michael Weichenthal

Front Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg.
Andrea Forschner, Katharina C Kähler, Martin Gschnell, Ewan A Langan, Carsten Weishaupt, Michael Weichenthal

Front Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg.
Julian Kött, Tim Zell, Noah Zimmermann, Alessandra Rünger, Daniel J Smit, Michael Weichenthal

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey.
Axel Hauschild, Claus Garbe, Paolo Antonio Ascierto, Lev Demidov, Brigitte Dreno, Michael Weichenthal

Lancet Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S2k guideline basal cell carcinoma of the skin (update 2023).
Berenice M Lang, Panagiotis Balermpas, Andrea Bauer, Andreas Blum, Thomas Dirschka, Michael Weichenthal

J Dtsch Dermatol Ges· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg.
Sebastian A Wohlfeil, Leonie Kranzmann, Christel Weiß, Imke von Wasielewski, Kai C Klespe, Michael Weichenthal

Int J Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus late response to PD-1-based immunotherapy in metastatic melanoma.
Georg C Lodde, Fang Zhao, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Michael Weichenthal

Eur J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.
Michael Weichenthal, Joanna Mangana, Iva Gavrilova, Iwona Lugowska, Gergana Krumova Shalamanova

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas.
Philipp Jansen, Wolfgang Galetzka, Georg C Lodde, Fabian Standl, Anne Zaremba, Michael Weichenthal

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.
Julian Kött, Noah Zimmermann, Tim Zell, Isabel Heidrich, Glenn Geidel, Michael Weichenthal

J Eur Acad Dermatol Venereol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' and dermatologists' preferences in artificial intelligence-driven skin cancer diagnostics: A prospective multicentric survey study.
Sarah Haggenmüller, Roman C Maron, Achim Hekler, Eva Krieghoff-Henning, Jochen S Utikal, Michael Weichenthal

J Am Acad Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases.
Ines Pires da Silva, Isabel Li, Selma Ugurel, Patricio Serra-Bellver, Avanti Andhale, Michael Weichenthal

Eur J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events.
Elias A T Koch, Anne Petzold, Edgar Dippel, Michael Erdmann, Anja Gesierich, Michael Weichenthal

Front Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications.
Anna M Halupczok, Ann-Sophie Bohne, Sascha Gerdes, Stephan Weidinger, Michael Weichenthal

Acta Derm Venereol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREG.
Corinna Kochanek, Catharina Gilde, Lisa Zimmer, Selma Ugurel, Friedegund Meier, Michael Weichenthal

Eur J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention].
Ulrike Leiter, Markus V Heppt, Theresa Steeb, Mareike Alter, Teresa Amaral, Michael Weichenthal

J Dtsch Dermatol Ges· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.
Markus V Heppt, Ulrike Leiter, Theresa Steeb, Mareike Alter, Teresa Amaral, Michael Weichenthal

J Dtsch Dermatol Ges· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis